Dual-layer detector spectral CT for predicting p16 status in head and neck squamous cell carcinoma

被引:1
作者
Li, Zhijun [1 ,2 ,3 ,4 ]
Ye, Lu [1 ,2 ,3 ,4 ]
Xiao, Jianyu [1 ,2 ,3 ,4 ]
Lu, Xiaomei [5 ]
Ye, Zhaoxiang [1 ,2 ,3 ,4 ]
机构
[1] Tianjin Med Univ, Dept Radiol, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc, Natl Clin Res Ctr Canc, Inst & Hosp, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[5] Philips Healthcare, CT Clin Sci CT, Shenyang, Peoples R China
关键词
Head and neck squamous cell carcinoma; Spectral CT; HPV; p16; Quantitative analysis; HUMAN-PAPILLOMAVIRUS; SURVIVAL;
D O I
10.1007/s42058-023-00123-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundHPV-positive head and neck squamous cell carcinoma (HNSCC) differs from HPV-negative HNSCC in clinical features, biological behavior, pathological manifestations, cytogenetics and tend to have better outcome. Immunohistochemical (IHC) p16 staining is highly sensitive for HPV status exam, but has a certain probability of false positives, and the accurate result of p16 expression could be challenging due to the limitation of the biopsy location and quantity. As a non-invasive approach, dual-layer detector spectral CT (DLSCT) provides multi-parameter quantitative analysis, which could help better reflect the changes of tumor characteristics. Hence, this study aimed to evaluate the spectral-derived differences between the p16( +) and p16(-) group of HNSCC so as to explore the application in preoperative diagnosis in differentiating the p16 expression status of HNSCC.Materials and methodsThe spectral data of 35 patients with biopsy confirmed HNSCC were retrospectively analyzed and compared between p16( +) (n = 11) and p16(-) (n = 25) group. All statistical analyses were performed on SPSS v26.0.ResultsEffective atomic number (Zeff), slope value of virtual monoenergetic image (VMI), and normalized iodine density (NID) of p16( +) group were all significantly lower than p16(-) group (8.36 (8.24, 8.42) vs. 8.57 (8.38, 8.85), 2.45 (2.22, 2.64) vs. 3.06 (2.50, 3.82), 0.43 & PLUSMN; 0.09 vs. 0.55 & PLUSMN; 0.14, respectively) (p < 0.05). Besides, NID showed a good ability to discriminate p16(-) HNSCC from p16( +) HNSCC (AUC = 0.788) with a threshold value of 0.495.ConclusionDLSCT could be helpful for the differentiation of p16 expression in HNSCC.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [31] Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes
    Arsa, Lalida
    Siripoon, Teerada
    Trachu, Narumol
    Foyhirun, Sasithorn
    Pangpunyakulchai, Duangjai
    Sanpapant, Suda
    Jinawath, Natini
    Pattaranutaporn, Poompis
    Jinawath, Artit
    Ngamphaiboon, Nuttapong
    BMC CANCER, 2021, 21 (01)
  • [32] p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck
    Becker, Anne-Sophie
    Merkel, Jenny
    Bozkurt, Inci
    Strueder, Daniel Fabian
    Maletzki, Claudia
    Huehns, Maja
    Zimpfer, Annette Helene
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (10): : 2569 - 2581
  • [33] The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas
    Jakscha, Jens
    Zlobec, Inti
    Storck, Claudio
    Obermann, Ellen C.
    Tornillo, Luigi
    Terracciano, Luigi M.
    Fischer, Claude A.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (02) : 661 - 667
  • [34] Treatment Outcomes of Squamous Cell Carcinoma of the Soft Palate and the Prognostic Significance of HPV/p16 Status
    Li, Meng-hua
    Zhang, Xing
    Li, Feng-jiao
    Gao, Xian-lu
    Yan, Shi-da
    Lin, Qiao-hong
    Li, Xi-yuan
    Meng, Jian
    Zhang, Ying
    Zhang, Shi-ting
    Chen, Shu-wei
    Song, Ming
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
  • [35] HPV, protein p16 and squamous cell carcinoma of the oral cavity
    Blahak, Jiri
    Zelinka, Jiri
    Gumulec, Jaromir
    Machacek, Ctirad
    Danek, Zdenek
    Bulik, Oliver
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (03): : 292 - 299
  • [36] MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway
    Macha, M. A.
    Rachagani, S.
    Pai, P.
    Gupta, S.
    Lydiatt, W. M.
    Smith, R. B.
    Johansson, S. L.
    Lele, S. M.
    Kakar, S. S.
    Lee, J. H.
    Meza, J.
    Ganti, A. K.
    Jain, M.
    Batra, S. K.
    ONCOGENE, 2015, 34 (13) : 1698 - 1708
  • [37] Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives
    Daste, Amaury
    Larroquette, Mathieu
    Gibson, Nyere
    Lasserre, Matthieu
    Domblides, Charlotte
    IMMUNOTHERAPY, 2024, 16 (03) : 187 - 197
  • [38] Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
    Biesaga, Beata
    Mucha-Malecka, Anna
    Janecka-Widla, Anna
    Kolodziej-Rzepa, Marta
    Szostek, Slawa
    Slonina, Dorota
    Kowalczyk, Aleksandra
    Halaszka, Krzysztof
    Przewoznik, Marcin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (01) : 63 - 73
  • [39] TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma
    von Buchwald, Christian
    Jakobsen, Kathrine Kronberg
    Carlander, Amanda-Louise Fenger
    Tous, Sara
    Gronhoj, Christian
    Rasmussen, Jacob H.
    Brooks, Jill
    Taberna, Miren
    Mena, Marisa
    Morey, Francisca
    Bruni, Laia
    Batis, Nikolaos
    Brakenhoff, Ruud H.
    Leemans, C. Rene
    de Jong, Robert J. Baatenburg
    Klussmann, Jens Peter
    Wuerdemann, Nora
    Wagner, Steffen
    Dalianis, Tina
    Marklund, Linda
    Mirghani, Haitham
    Schache, Andrew
    James, Jaqueline A.
    Huang, Shao Hui
    O'Sullivan, Brian
    Nankivell, Paul
    Broglie, Martina A.
    Hoffmann, Markus
    Quabius, Elgar Susanne
    Anderson, Lesley A.
    Craig, Stephanie G.
    Alemany, Laia
    Mehanna, Hisham
    EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [40] Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma
    Maebayashi, Toshiya
    Ishibashi, Naoya
    Aizawa, Takuya
    Sakaguchi, Masakuni
    Saito, Tsutomu
    Kawamori, Jiro
    Tanaka, Yoshiaki
    Hirotani, Yukari
    Homma, Taku
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (04) : 1221 - 1229